Page last updated: 2024-10-25

chlorpropamide and Neoplasms

chlorpropamide has been researched along with Neoplasms in 9 studies

Chlorpropamide: A sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277)
chlorpropamide : An N-sulfonylurea that is urea in which a hydrogen attached to one of the nitrogens is substituted by 4-chlorobenzenesulfonyl group and a hydrogen attached to the other nitrogen is substituted by propyl group. Chlorpropamide is a hypoglycaemic agent used in the treatment of type 2 (non-insulin-dependent) diabetes mellitus not responding to dietary modification.

Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Research Excerpts

ExcerptRelevanceReference
"In AZD6244-resistant cancer cells, we observed the impaired nuclear localization of FOXO3a, reduced FOXO3a-mediated transcriptional activity, and decreased the expression of FOXO3a target gene Bim after cell treatment with AZD6244."1.36Activation of FOXO3a is sufficient to reverse mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor chemoresistance in human cancer. ( Andreeff, M; Chang, CJ; Du, Y; Engelman, JA; Hortobagyi, GN; Hung, MC; Wang, Y; Wong, KK; Xia, W; Yang, JY, 2010)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19901 (11.11)18.7374
1990's0 (0.00)18.2507
2000's5 (55.56)29.6817
2010's3 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Diamandis, P1
Wildenhain, J1
Clarke, ID1
Sacher, AG1
Graham, J1
Bellows, DS1
Ling, EK1
Ward, RJ1
Jamieson, LG1
Tyers, M1
Dirks, PB1
Lin, R1
Elf, S1
Shan, C1
Kang, HB1
Ji, Q1
Zhou, L1
Hitosugi, T1
Zhang, L1
Zhang, S1
Seo, JH1
Xie, J1
Tucker, M1
Gu, TL1
Sudderth, J1
Jiang, L1
Mitsche, M1
DeBerardinis, RJ1
Wu, S1
Li, Y1
Mao, H1
Chen, PR1
Wang, D1
Chen, GZ1
Hurwitz, SJ1
Lonial, S1
Arellano, ML1
Khoury, HJ1
Khuri, FR1
Lee, BH1
Lei, Q1
Brat, DJ1
Ye, K1
Boggon, TJ1
He, C1
Kang, S1
Fan, J1
Chen, J1
Shimura, T1
Noma, N1
Sano, Y1
Ochiai, Y1
Oikawa, T1
Fukumoto, M1
Kunugita, N1
Noh, KH1
Kang, TH1
Kim, JH1
Pai, SI1
Lin, KY1
Hung, CF1
Wu, TC1
Kim, TW1
Yang, JY1
Chang, CJ1
Xia, W1
Wang, Y1
Wong, KK1
Engelman, JA1
Du, Y1
Andreeff, M1
Hortobagyi, GN1
Hung, MC1
Mukoyama, M1
Nakao, K1
Wilkin, JK1
Sládek, NE2
Rekha, GK2
Lee, MJ2
Nagasawa, HT2

Reviews

3 reviews available for chlorpropamide and Neoplasms

ArticleYear
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
    Nature cell biology, 2015, Volume: 17, Issue:11

    Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms;

2015
[Syndrome of inappropriate secretion of antidiuretic hormone].
    Nihon rinsho. Japanese journal of clinical medicine, 2006, May-28, Volume: Suppl 1

    Topics: Central Nervous System Diseases; Chlorpropamide; Diagnosis, Differential; Furosemide; Humans; Inappr

2006
Flushing reactions: consequences and mechanisms.
    Annals of internal medicine, 1981, Volume: 95, Issue:4

    Topics: Chlorpropamide; Disulfiram; Drug Interactions; Endorphins; Ethanol; Female; Glutamates; Hot Temperat

1981

Other Studies

6 other studies available for chlorpropamide and Neoplasms

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutic

2007
AKT-mediated enhanced aerobic glycolysis causes acquired radioresistance by human tumor cells.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2014, Volume: 112, Issue:2

    Topics: Aerobiosis; Cell Death; Chlorpropamide; Deoxyglucose; Glucose; Glucose Transporter Type 1; Glycolysi

2014
Activation of Akt as a mechanism for tumor immune evasion.
    Molecular therapy : the journal of the American Society of Gene Therapy, 2009, Volume: 17, Issue:3

    Topics: Animals; Apoptosis; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Chlorpropamide; Enzyme Activation;

2009
Activation of FOXO3a is sufficient to reverse mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor chemoresistance in human cancer.
    Cancer research, 2010, Jun-01, Volume: 70, Issue:11

    Topics: Animals; Apoptosis; Benzimidazoles; Breast Neoplasms; Cell Growth Processes; Cell Line, Tumor; Chlor

2010
Inhibition of ALDH3A1-catalyzed oxidation by chlorpropamide analogues.
    Chemico-biological interactions, 2001, Jan-30, Volume: 130-132, Issue:1-3

    Topics: Aldehyde Dehydrogenase; Chlorpropamide; Enzyme Inhibitors; Gastric Mucosa; Humans; In Vitro Techniqu

2001
Inhibition of ALDH3A1-catalyzed oxidation by chlorpropamide analogues.
    Chemico-biological interactions, 2001, Nov-28, Volume: 138, Issue:2

    Topics: Aldehyde Dehydrogenase; Aldehyde Dehydrogenase 1 Family; Aldehyde Dehydrogenase, Mitochondrial; Chlo

2001